IRIS
COVRE, ALESSIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.919
EU - Europa 2.811
AS - Asia 1.855
SA - Sud America 307
AF - Africa 104
OC - Oceania 9
Totale 9.005
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.860
RU - Federazione Russa 866
SG - Singapore 748
IT - Italia 572
IE - Irlanda 434
CN - Cina 433
VN - Vietnam 254
BR - Brasile 252
GB - Regno Unito 239
FR - Francia 184
HK - Hong Kong 159
SE - Svezia 135
DE - Germania 110
UA - Ucraina 77
ZA - Sudafrica 74
FI - Finlandia 67
IN - India 61
KR - Corea 47
ES - Italia 40
CA - Canada 33
BD - Bangladesh 29
NL - Olanda 20
PL - Polonia 18
IQ - Iraq 17
MX - Messico 16
TR - Turchia 14
AT - Austria 13
EC - Ecuador 13
AR - Argentina 12
JO - Giordania 10
ID - Indonesia 9
JP - Giappone 9
KE - Kenya 9
AU - Australia 8
AL - Albania 7
AZ - Azerbaigian 7
PH - Filippine 7
CL - Cile 6
CO - Colombia 6
UY - Uruguay 6
LT - Lituania 5
MA - Marocco 5
SA - Arabia Saudita 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
BE - Belgio 4
DZ - Algeria 4
IL - Israele 4
NP - Nepal 4
PY - Paraguay 4
CR - Costa Rica 3
MY - Malesia 3
NO - Norvegia 3
PA - Panama 3
PE - Perù 3
PK - Pakistan 3
RO - Romania 3
AM - Armenia 2
CH - Svizzera 2
EG - Egitto 2
ET - Etiopia 2
HR - Croazia 2
IR - Iran 2
KG - Kirghizistan 2
KH - Cambogia 2
KW - Kuwait 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LV - Lettonia 2
NG - Nigeria 2
OM - Oman 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
UZ - Uzbekistan 2
BG - Bulgaria 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
CZ - Repubblica Ceca 1
EE - Estonia 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
IM - Isola di Man 1
LB - Libano 1
MR - Mauritania 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
PT - Portogallo 1
SV - El Salvador 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 9.005
Salva come PNG Salva come JPEG
Città #
Dallas 736
Dublin 431
Singapore 426
Fairfield 407
Ashburn 282
Moscow 248
Santa Clara 221
Woodbridge 183
Seattle 176
San Jose 164
Cambridge 158
Houston 156
Hong Kong 155
Wilmington 153
Southend 150
Beijing 140
New York 95
Hefei 79
Milan 75
Jacksonville 73
Princeton 73
Siena 72
The Dalles 72
Los Angeles 71
Ho Chi Minh City 70
Johannesburg 70
Lauterbourg 68
Florence 64
Dong Ket 50
Council Bluffs 49
Helsinki 47
Ann Arbor 44
Seoul 44
Shanghai 44
Hanoi 43
Rome 38
San Mateo 38
San Diego 34
Chandler 30
Munich 27
Málaga 27
Dearborn 25
Stockholm 22
São Paulo 22
Redondo Beach 21
Borgo San Lorenzo 20
London 17
Buffalo 16
Lappeenranta 16
Orem 16
Chennai 15
Denver 15
Fremont 15
Chicago 14
Montreal 14
Frankfurt am Main 13
Nuremberg 13
Warsaw 13
Haiphong 12
Palermo 12
Toronto 12
Atlanta 11
Phoenix 11
Poplar 11
San Francisco 11
Amsterdam 10
Empoli 10
Guangzhou 10
Manchester 10
Sesto Fiorentino 10
Vienna 10
Bengaluru 9
Guayaquil 9
Perugia 9
Rio de Janeiro 9
Tokyo 9
Amman 8
Da Nang 8
Portsmouth 8
Brooklyn 7
Mumbai 7
Naples 7
Piscataway 7
Barnet 6
Boardman 6
Cascina 6
Charlotte 6
Düsseldorf 6
Lucca 6
Mexico City 6
Montevideo 6
Ninh Bình 6
Orbetello 6
Redwood City 6
Sydney 6
Trieste 6
Asciano 5
Baku 5
Bắc Ninh 5
Labico 5
Totale 6.205
Salva come PNG Salva come JPEG
Nome #
Neurological adverse events of ICI therapy: A ten-year comprehensive management from a multidisciplinary team 470
Immunomodulatory properties of DNA hypomethylating agents: Selecting the optimal epigenetic partner for cancer immunotherapy 253
Circulating levels of PD-L1 in mesothelioma patients from the NIBIT-MESO-1 study: Correlation with survival 242
Fourteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT) on Cancer Bio-Immunotherapy, Siena, Italy, October 13–15, 2016 236
A vision of immuno-oncology: the Siena think tank of the Italian network for tumor biotherapy (NIBIT) foundation 220
NK- and T-cell subsets in malignant mesothelioma patients: Baseline pattern and changes in the context of anti-CTLA-4 therapy 219
Guadecitabine plus ipilimumab in unresectable melanoma: the NIBIT-M4 clinical trial 218
Epigenetic remodeling to improve the efficacy of immunotherapy in human glioblastoma: pre-clinical evidence for development of new immunotherapy approaches 207
Antitumor activity of epigenetic immunomodulation combined with CTLA-4 blockade in syngeneic mouse models 205
Targeting cancer vasculature via endoglin/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumours 204
Fifteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT) on Cancer Bio-Immunotherapy, Siena, Italy, October 5–7, 2017 203
Epigenetically regulated clonal heritability of CTA expression profiles in human melanoma 201
“Cancer Bio-Immunotherapy in Siena”: Eleventh Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 17–19, 2013 190
Epigenetic immune remodeling of mesothelioma cells: A new strategy to improve the efficacy of immunotherapy 188
Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies 185
Expression and regulation of B7-H3 immunoregulatory receptor, in human mesothelial and mesothelioma cells: immunotherapeutic implications 183
A novel microRNA signature for the detection of melanoma by liquid biopsy 178
Epigenetically-regulated Tumor-Associated Antigens in melanoma 178
The biology of cancer testis antigens: putative function, regulation and therapeutic potential 177
Guadecitabine plus ipilimumab in unresectable melanoma: five-year follow-up and integrated multi-omic analysis in the phase 1b NIBIT-M4 trial 172
Immunotherapy targeting immune check-point(s) in brain metastases 172
Tremelimumab plus durvalumab retreatment and 4-year outcomes in patients with mesothelioma: a follow-up of the open label, non-randomised, phase 2 NIBIT-MESO-1 study 172
5-AZA-2'-deoxycytidine in cancer immunotherapy: a mouse to man story 169
Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapy 167
Molecular pathways: At the crossroads of cancer epigenetics and immunotherapy 158
Tenth annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), SIENA, Italy, November 5-7, 2012 157
Whole genome methylation profiles as independent markers of survival in stage IIIc melanoma patients 153
Epigenetic remodelling of gene expression profiles of neoplastic and normal tissues: immunotherapeutic implications 153
A phase Ib study combining the second-generation DNA hypomethylating agent (DHA) guadecitabine (SGI-110) and ipilimumab in patients with metastatic melanoma: the NIBIT-M4 Study. 153
Epigenetically‐Regulated Therapeutic Tumor‐Associated Antigens 148
Challenges in lung cancer therapy during the COVID-19 pandemic 144
Prognostic Potential of Integrated Whole Genome Methylation and Expression Profiling in Cutaneous Melanoma 139
Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications 139
Immune Checkpoint Inhibitors for Cancer Therapy in the COVID-19 Era 138
Methylation levels of the "long interspersed nucleotide element-1" repetitive sequences predict survival of melanoma patients 133
Cancer testis antigens in human melanoma stem cells: expression, distribution, and methylation status 131
Nivolumab plus ipilimumab in melanoma patients with asymptomatic brain metastases: 7-year outcomes and quality of life from the multicenter phase III NIBIT-M2 trial 130
COVID and Lung Cancer 130
Epigenetics meets immune checkpoints 128
Cancer testis antigens and melanoma stem cells: new promises for therapeutic intervention. 124
Safety and immunobiological activity of guadecitabine sequenced with ipilimumab in metastatic melanoma patients: The phase Ib NIBIT-M4 study 122
Immunotherapy of mesothelioma: the evolving change of a long-standing therapeutic dream 117
Epigenetic mechanisms in cancer formation and progression 111
The Italian Network for Tumor Bio-Immunotherapy (NIBIT) Foundation: ongoing and prospective activities in immuno-oncology 111
Immunotherapy in melanoma: Can we predict response to treatment with circulating biomarkers? 109
Epigenetics of melanoma: implications for immune-based therapies. Immunotherapy, 5:1103-1116, 2013 108
Tremelimumab combined with durvalumab in patients with mesothelioma (NIBIT-MESO-1): an open-label, non-randomised, phase 2 study 107
Immunomodulatory activity of SGI-110, a 5-aza-2 '-deoxycytidine-containing demethylating dinucleotide 103
Primary analysis and 4-year follow-up of the phase III NIBIT-M2 trial in melanoma patients with brain metastases 96
Clonal heritability of CTA expression and promoter methylation patterns in melanoma cells: Bases for epigenetic therapy? 89
Immunotherapy of brain metastases: breaking a "dogma" 86
The pleiotropic roles of circular and long noncoding RNAs in cutaneous melanoma 83
Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI) 81
Loss of Spry1 reduces growth of BRAFV600-mutant cutaneous melanoma and improves response to targeted therapy 79
Whole genome methylation profiles and survival of melanoma patients 75
DNA methylation status classifies pleural mesothelioma cells according to their immune profile: implication for precision epigenetic therapy 74
Personalized Medicine for Patients with Liver, Biliary Tract, and Pancreatic Cancer 67
Immunomodulatory activity of SGI-110, a secon generation hypometilating agent 60
The Immunomodulatory Activity of Thymosin Alpha 1 on Tumor Cell Lines and Distinct Immune Cell Subsets 59
Characterization and identification of vaccine candidate proteins through analysis of the group A Streptococcus surface proteome 56
Abstract 4841: DNA methylation status classifies pleural mesothelioma cells according to their immune profile: implication for precision epigenetic therapy 56
Abstract 2632: A new paradigm for brain tumors treatment: Guadecitabine as a fundamental player to improve tumor immune response 56
Integrated multi-omics profiling reveals the role of the DNA methylation landscape in shaping biological heterogeneity and clinical behaviour of metastatic melanoma 52
Totale 9.224
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.255
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.255
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021209 0 0 0 0 0 0 0 0 0 72 32 105
2021/2022460 13 61 42 10 8 30 20 19 31 58 63 105
2022/2023517 50 36 103 49 11 94 17 29 41 29 41 17
2023/2024753 31 19 71 27 22 215 235 26 27 9 24 47
2024/20251.516 58 42 133 88 205 99 40 86 191 81 163 330
2025/20264.008 251 405 686 523 976 183 469 166 148 201 0 0
Totale 9.224